Hyperbilirubinemia. Physiological jaundice (intense)(prolonged) NOS
Conditions
Interventions
Intervention 1: Intervention group: The intervention group receive Fenofibrate 10mg/kg. Intervention 2: control group: The control group receive placebo.
Treatment - Drugs
Intervention group: The intervention group receive Fenofibrate 10mg/kg.
control group: The control group receive placebo.
Sponsors
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: full-term newborns, with of age of more than 72 hour and serum bilirubin level more than 15 mg/dl. Exclusion criteria: Preterm infants, IUGR, Congenital anomaly, Respiratory distress, sepsis.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin's level. Timepoint: Total serum bilirubin level measured at the time of admission, daily during the hospitalization and at the time of the discharge. Method of measurement: Bilirubin was checked by diazo (Photometr) method by farazkave therapy kits that producing in Iran. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration phototherapy unresponsive to phototherapy, severe hyperbilirubinemia need to exchange. Timepoint: Time of admission and time of discharge. Method of measurement: Auto analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Maryam Vafaeinezhad
Amirkola Children’s Hospital
Outcome results
None listed